Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C B Lock

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Singapore Medical Journal|June 1, 1980
Cardiovascular research in the University Department of Medicine over the last two decadesC B Lock
Singapore Medical Journal|December 1, 1978
Dilemmas in coronary artery diseaseC B Lock
Singapore Medical Journal|February 1, 1981
Two dimensional echocardiographyC B Lock, B Ee
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1989
Genetic factors in sleep disordersJ D Parkes, C B Lock
Immunological Reviews|December 1, 1990
Antigen recognition and peptide-mediated immunotherapy in autoimmune diseaseD E Smilek, C B Lock, H O McDevitt
Sleep|October 1, 1987
Selegiline in narcolepsyS E Roselaar, N Langdon, C B Lock, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 21, 1994
Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region beta-chain T-cell repertoire and mediates an HLA-DR-restricted immune responseL Fugger, S A Michie, I Rulifson, et al.
Immunogenetics|January 1, 1988
MHC class II sequences of an HLA-DR2 narcolepticC B Lock, A K So, K I Welsh, et al.
Multiple Sclerosis and Related Disorders|July 21, 2021
A variant of uncertain significance in SDHAF1, the succinate dehydrogenase chaperone protein, in an adult patient with spastic paraparesis and leukoencephalopathyL Vlahovic, C B Lock, M H Han, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 18, 1994
Minimum structural requirements for peptide presentation by major histocompatibility complex class II molecules: implications in induction of autoimmunityA M Gautam, C B Lock, D E Smilek, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Singapore Medical Journal|June 1, 1980
Cardiovascular research in the University Department of Medicine over the last two decadesC B Lock
Singapore Medical Journal|December 1, 1978
Dilemmas in coronary artery diseaseC B Lock
Singapore Medical Journal|February 1, 1981
Two dimensional echocardiographyC B Lock, B Ee
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1989
Genetic factors in sleep disordersJ D Parkes, C B Lock
Immunological Reviews|December 1, 1990
Antigen recognition and peptide-mediated immunotherapy in autoimmune diseaseD E Smilek, C B Lock, H O McDevitt
Sleep|October 1, 1987
Selegiline in narcolepsyS E Roselaar, N Langdon, C B Lock, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 21, 1994
Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region beta-chain T-cell repertoire and mediates an HLA-DR-restricted immune responseL Fugger, S A Michie, I Rulifson, et al.
Immunogenetics|January 1, 1988
MHC class II sequences of an HLA-DR2 narcolepticC B Lock, A K So, K I Welsh, et al.
Multiple Sclerosis and Related Disorders|July 21, 2021
A variant of uncertain significance in SDHAF1, the succinate dehydrogenase chaperone protein, in an adult patient with spastic paraparesis and leukoencephalopathyL Vlahovic, C B Lock, M H Han, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 18, 1994
Minimum structural requirements for peptide presentation by major histocompatibility complex class II molecules: implications in induction of autoimmunityA M Gautam, C B Lock, D E Smilek, et al.
Pageof 2